HBC Immunology Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Observe Change in Nasal Swab DRD2 Gene Expression in Restless Legs Syndrome (RLS) Patients on Prolonged Dopamine Agonist Treatment (NCT06726785) | HBC Immunology Inc | 2025-07-01 |
Track HBC Immunology Inc automatically
Every clearance here is in the API, with alerts when new ones post.